Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems
Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the chal...
Gespeichert in:
Veröffentlicht in: | Veterinary Pathology 2010, Vol.47 (1), p.58-76 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 76 |
---|---|
container_issue | 1 |
container_start_page | 58 |
container_title | Veterinary Pathology |
container_volume | 47 |
creator | Perkins, L.E. Leigh |
description | Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed. |
doi_str_mv | 10.1177/0300985809352978 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733791406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0300985809352978</sage_id><sourcerecordid>733791406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq2Kqmxp7z2Bb5zSju3Edo4Ith8SVasunC0nGS9G3nixEyT-fb0K5cChp5FmnveR5iXkE4PPjCn1BQRAqxsNrWh4q_QbsmJNXVecM3VEVodzdbgfk_c53wNw3mr1jhxzAA21livififsgx99bwP9GQcMmUZH_2CecIzZZ2rHgd7coU_0Yr8PhZt8HKkf6XSHdP1ow7xsSuoqzdtqHebJj1u6KYKJbp6KaJc_kLfOhowfn-cJuf26vrn8Xl3_-vbj8uK66mvgU8U7ENg0XdO5Xgy9At0hxxakRDeoFpizHQfBmGxt10jZ9SBRI3BRO944IU7I-eLdp_gwlyfMzuceQ7AjxjkbJYRqWQ2ykLCQfYo5J3Rmn_zOpifDwBzKNa_LLZHTZ_nc7XB4CfxrswDVAmS7RXMf5zSWZ_8nPFt4Z6Ox2-Szud1wYAKYZpzLWvwFF52K0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733791406</pqid></control><display><type>article</type><title>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Perkins, L.E. Leigh</creator><creatorcontrib>Perkins, L.E. Leigh</creatorcontrib><description>Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed.</description><identifier>ISSN: 0300-9858</identifier><identifier>EISSN: 1544-2217</identifier><identifier>DOI: 10.1177/0300985809352978</identifier><identifier>PMID: 20080486</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>animal disease models ; Animals ; coronary artery disease ; Coronary Disease - therapy ; Coronary Restenosis - prevention & control ; Coronary Restenosis - therapy ; coronary vessels ; Disease Models, Animal ; Dogs ; drug delivery systems ; Drug-Eluting Stents - adverse effects ; endovascular stents ; equipment performance ; in-stent restenosis ; literature reviews ; medical equipment ; medical treatment ; Mice ; pathophysiology ; percutaneous coranary intervention ; Primates ; Rabbits ; Rats ; Sheep ; Swine ; transdermal application ; vascular diseases</subject><ispartof>Veterinary Pathology, 2010, Vol.47 (1), p.58-76</ispartof><rights>The American College of Veterinary Pathologists 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</citedby><cites>FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0300985809352978$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0300985809352978$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>313,314,776,780,788,4009,21799,27901,27902,27903,27904,43600,43601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20080486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perkins, L.E. Leigh</creatorcontrib><title>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</title><title>Veterinary Pathology</title><addtitle>Vet Pathol</addtitle><description>Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed.</description><subject>animal disease models</subject><subject>Animals</subject><subject>coronary artery disease</subject><subject>Coronary Disease - therapy</subject><subject>Coronary Restenosis - prevention & control</subject><subject>Coronary Restenosis - therapy</subject><subject>coronary vessels</subject><subject>Disease Models, Animal</subject><subject>Dogs</subject><subject>drug delivery systems</subject><subject>Drug-Eluting Stents - adverse effects</subject><subject>endovascular stents</subject><subject>equipment performance</subject><subject>in-stent restenosis</subject><subject>literature reviews</subject><subject>medical equipment</subject><subject>medical treatment</subject><subject>Mice</subject><subject>pathophysiology</subject><subject>percutaneous coranary intervention</subject><subject>Primates</subject><subject>Rabbits</subject><subject>Rats</subject><subject>Sheep</subject><subject>Swine</subject><subject>transdermal application</subject><subject>vascular diseases</subject><issn>0300-9858</issn><issn>1544-2217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P3DAQhq2Kqmxp7z2Bb5zSju3Edo4Ith8SVasunC0nGS9G3nixEyT-fb0K5cChp5FmnveR5iXkE4PPjCn1BQRAqxsNrWh4q_QbsmJNXVecM3VEVodzdbgfk_c53wNw3mr1jhxzAA21livififsgx99bwP9GQcMmUZH_2CecIzZZ2rHgd7coU_0Yr8PhZt8HKkf6XSHdP1ow7xsSuoqzdtqHebJj1u6KYKJbp6KaJc_kLfOhowfn-cJuf26vrn8Xl3_-vbj8uK66mvgU8U7ENg0XdO5Xgy9At0hxxakRDeoFpizHQfBmGxt10jZ9SBRI3BRO944IU7I-eLdp_gwlyfMzuceQ7AjxjkbJYRqWQ2ykLCQfYo5J3Rmn_zOpifDwBzKNa_LLZHTZ_nc7XB4CfxrswDVAmS7RXMf5zSWZ_8nPFt4Z6Ox2-Szud1wYAKYZpzLWvwFF52K0A</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Perkins, L.E. Leigh</creator><general>SAGE Publications</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</title><author>Perkins, L.E. Leigh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>animal disease models</topic><topic>Animals</topic><topic>coronary artery disease</topic><topic>Coronary Disease - therapy</topic><topic>Coronary Restenosis - prevention & control</topic><topic>Coronary Restenosis - therapy</topic><topic>coronary vessels</topic><topic>Disease Models, Animal</topic><topic>Dogs</topic><topic>drug delivery systems</topic><topic>Drug-Eluting Stents - adverse effects</topic><topic>endovascular stents</topic><topic>equipment performance</topic><topic>in-stent restenosis</topic><topic>literature reviews</topic><topic>medical equipment</topic><topic>medical treatment</topic><topic>Mice</topic><topic>pathophysiology</topic><topic>percutaneous coranary intervention</topic><topic>Primates</topic><topic>Rabbits</topic><topic>Rats</topic><topic>Sheep</topic><topic>Swine</topic><topic>transdermal application</topic><topic>vascular diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perkins, L.E. Leigh</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary Pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perkins, L.E. Leigh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</atitle><jtitle>Veterinary Pathology</jtitle><addtitle>Vet Pathol</addtitle><date>2010</date><risdate>2010</risdate><volume>47</volume><issue>1</issue><spage>58</spage><epage>76</epage><pages>58-76</pages><issn>0300-9858</issn><eissn>1544-2217</eissn><abstract>Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>20080486</pmid><doi>10.1177/0300985809352978</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-9858 |
ispartof | Veterinary Pathology, 2010, Vol.47 (1), p.58-76 |
issn | 0300-9858 1544-2217 |
language | eng |
recordid | cdi_proquest_miscellaneous_733791406 |
source | MEDLINE; SAGE Complete A-Z List |
subjects | animal disease models Animals coronary artery disease Coronary Disease - therapy Coronary Restenosis - prevention & control Coronary Restenosis - therapy coronary vessels Disease Models, Animal Dogs drug delivery systems Drug-Eluting Stents - adverse effects endovascular stents equipment performance in-stent restenosis literature reviews medical equipment medical treatment Mice pathophysiology percutaneous coranary intervention Primates Rabbits Rats Sheep Swine transdermal application vascular diseases |
title | Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T12%3A19%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preclinical%20Models%20of%20Restenosis%20and%20Their%20Application%20in%20the%20Evaluation%20of%20Drug-Eluting%20Stent%20Systems&rft.jtitle=Veterinary%20Pathology&rft.au=Perkins,%20L.E.%20Leigh&rft.date=2010&rft.volume=47&rft.issue=1&rft.spage=58&rft.epage=76&rft.pages=58-76&rft.issn=0300-9858&rft.eissn=1544-2217&rft_id=info:doi/10.1177/0300985809352978&rft_dat=%3Cproquest_cross%3E733791406%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733791406&rft_id=info:pmid/20080486&rft_sage_id=10.1177_0300985809352978&rfr_iscdi=true |